Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 76 articles:
HTML format
Text format



Single Articles


    November 2016
  1. ORDIERES C, Navascues CA, Gonzalez-Dieguez ML, Rodriguez M, et al
    Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  2. SELLIER PO, Maylin S, Bercot B, Chopin D, et al
    Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  3. SILVA MJ, Valente J, Capela T, Russo P, et al
    Epidemiology of hepatitis B in Portugal.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  4. LAPI F, Capogrosso Sansone A, Mantarro S, Simonetti M, et al
    Hepatitis C virus infection: opportunities for an earlier detection in primary care.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  5. WALLACE SJ, Webb GW, Madden RG, Dalton HC, et al
    Investigation of liver dysfunction: who should we test for hepatitis E?
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  6. MCEWAN P, Selvapatt N, Brown A, Thursz M, et al
    A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  7. TURNER BJ, Liang Y, Singal A
    FIB-4 and imaging for measuring fibrosis in hepatitis C virus.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  8. NORDSTROM EM, Keniston A, Baouchi F, Martinez-Camacho A, et al
    Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  9. LI X, Gao F, Liu H, Zhang H, et al
    Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  10. WIJARNPREECHA K, Thongprayoon C, Ungprasert P
    Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  11. WIJARNPREECHA K, Thongprayoon C, Panjawatanan P, Manatsathit W, et al
    Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  12. ARDESIA M, Costantino G, Fries W
    Lower response to the hepatitis B vaccine in future inflammatory bowel disease patients.
    Eur J Gastroenterol Hepatol. 2016;28:1101-2.
    PubMed     Text format    


  13. BURLONE ME, Pedrinelli AR, Giarda P, Minisini R, et al
    Influence of age on sex-related differences among patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2016;28:1100-1.
    PubMed     Text format    


    August 2016
  14. SCHULZ M, Beha D, Plehm K, Zollner C, et al
    High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  15. LEWIS H, Kunkel J, Axten D, Dalton J, et al
    Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  16. BERT F, Rindermann A, Abdelfattah MA, Stahmeyer JT, et al
    High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  17. PARK CH, Kim HY, Lee SW, Song DS, et al
    On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  18. MANCEBO M, Real LM, Mira JA, Recio E, et al
    Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  19. DYSON JK, Jopson L, Ng S, Lowery M, et al
    Improving testing for hepatitis B before treatment with rituximab.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  20. WANG P, Huang G, Tam N, Wu C, et al
    Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  21. PIERUCKA M, Stalke P, Zagozdzon P, Smiatacz T, et al
    The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  22. MARCELLIN F, Fournier I, Carrieri MP, Poizot-Martin I, et al
    From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).
    Eur J Gastroenterol Hepatol. 2016;28:733-4.
    PubMed     Text format    


    May 2016
  23. KARAKOYUN M, Ecevit CO, Kilicoglu E, Aydogdu S, et al
    Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  24. MARCELLIN F, Protopopescu C, Poizot-Martin I, Miailhes P, et al
    Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  25. WANG H, Xu H, Qu L, Wang X, et al
    Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  26. TOSON EA, Shiha GE, El-Mezayen HA, El-Sharkawy AM, et al
    Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  27. YILMAZ B, Unlu O, Evcen R, Ugurluoglu C, et al
    Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?
    Eur J Gastroenterol Hepatol. 2016;28:607-8.
    PubMed     Text format    


    April 2016
  28. ZEUZEM S, Mantry P, Soriano V, Buynak RJ, et al
    Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  29. KARAGOZ E, Tanoglu A, Ulcay A, Erdem H, et al
    Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  30. LISON H, Garioud A, Halfon P, Jambon S, et al
    Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Eur J Gastroenterol Hepatol. 2016;28:486-7.
    PubMed     Text format    


    March 2016
  31. GULATI R, Nawaz M, Pyrsopoulos NT
    Comparative analysis of online patient education material pertaining to hepatitis and its complications.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  32. BOTTERO J, Boyd A, Gozlan J, Carrat F, et al
    Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  33. DINTSIOS CM
    Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).
    Eur J Gastroenterol Hepatol. 2016;28:362.
    PubMed     Text format    


  34. OZARAS R, Tahan V, Tabak F
    More on autoimmune hepatitis and acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2016;28:360.
    PubMed     Text format    


    February 2016
  35. WASZCZUK E, Waszczuk KM, Mulak A, Paradowski L, et al
    Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  36. HELAL GK, Gad MA, Abd-Ellah MF, Mahgoup EM, et al
    Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  37. CARVALHANA SC, Leitao J, Alves AC, Bourbon M, et al
    Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  38. CORSI DJ, Karges W, Thavorn K, Crawley AM, et al
    Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  39. NIEDERAU C, Amani A, Thiel A
    Long-term follow-up of HBsAg-positive patients in Germany.
    Eur J Gastroenterol Hepatol. 2016;28:48-56.
    PubMed     Text format     Abstract available


    December 2015
  40. HUNTER JG, Madden RG, Stone AM, Osborne N, et al
    Locally acquired hepatitis E in Cornwall, the UK; geographical clustering, environmental and social factors: a case-controlled study coastal clustering of HEV; Cornwall, UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  41. SELLIER PO, Schnepf N, Amarsy R, Maylin S, et al
    Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  42. OZDEN HT
    Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  43. WANG H, Innes H, Hutchinson SJ, Goldberg DJ, et al
    The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  44. AIZAWA Y, Abe H, Sugita T, Seki N, et al
    Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  45. CHENG XP, Zhao J, Chen Y, Meng FK, et al
    Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  46. SAEZ-ROYUELA F, Linares P, Cervera LA, Almohalla C, et al
    Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  47. ABDEL-RAZIK A, Mousa N, Abdel-Aziz M, Elhelaly R, et al
    Elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  48. LAW ST, Lee MK, Li KK, Mok CK, et al
    Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  49. DETERDING K, Gruner N, Buggisch P, Galle PR, et al
    Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  50. MARTIN DJ, Weideman R, Crook T, Brown G, et al
    Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  51. FEILLANT M, Jezequel C, Lison H, Delluc A, et al
    Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  52. MCEWAN P, Bennett H, Ward T, Webster S, et al
    The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  53. PATRICIO JA JR, Lopes PF, Medeiros T, Mendes GF, et al
    Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  54. KOHLA MA, El-Said H, El-Fert A, Ehsan N, et al
    Impact of nitazoxanide on sustained virologic response in Egyptian patients with chronic hepatitis C genotype 4: a double-blind placebo-controlled trial.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  55. NICOLINI LA, Menzaghi B, Ricci E, Martinelli C, et al
    Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  56. FUJIWARA K, Yasui S, Yokosuka O
    Appropriate diagnostic criteria for fulminant autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015;27:1230-1.
    PubMed     Text format    


  57. BASYIGIT S, Sapmaz F
    Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Eur J Gastroenterol Hepatol. 2015;27:1230.
    PubMed     Text format    


  58. KESKIN O, Idilman R
    Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis.
    Eur J Gastroenterol Hepatol. 2015;27:1228-9.
    PubMed     Text format    


    September 2015
  59. EMINLER AT, Ayyildiz T, Irak K, Kyc M, et al
    AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  60. RUDLER M, Thibault V, Mouri S, Akhavan S, et al
    Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  61. HAN SH, Suk KT, Kim DJ, Kim MY, et al
    Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  62. PANG Q, Bi JB, Xu XS, Liu SS, et al
    King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  63. SERRES L, Vasseur P, Tougeron D, Gand E, et al
    Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  64. BELLE A, Baumann C, Bigard MA, Zallot C, et al
    Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Eur J Gastroenterol Hepatol. 2015;27:877-81.
    PubMed     Text format     Abstract available


  65. TRIPPOLI S, Fadda V, Maratea D, Messori A, et al
    Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015;27:983-4.
    PubMed     Text format    


    July 2015
  66. KHEDR MA, E Behairy B, Hussein ME, Marei AM, et al
    Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  67. VERGARA M, Bejarano G, Dalmau B, Gil M, et al
    Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2015;27:826-833.
    PubMed     Text format     Abstract available


    June 2015
  68. ABDEL-GHAFFAR TY, Sira MM, Sira AM, Salem TA, et al
    Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  69. PACOU M, Basso F, Gore C, Hass B, et al
    Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  70. OZARAS R, Tahan V, Ozbay G, Ozturk R, et al
    Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  71. CHEN G, Liu H, Hu ZQ, Bai JH, et al
    A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  72. ABDELFATTAH MR, Elsiesy H
    Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.
    Eur J Gastroenterol Hepatol. 2015;27:593-9.
    PubMed     Text format     Abstract available


    February 2015
  73. KAYADIBI H, Sertoglu E, Uyanik M
    Which diagnostic tool for the prediction of intermediate liver fibrosis stages?
    Eur J Gastroenterol Hepatol. 2015;27:182.
    PubMed     Text format    


    January 2015
  74. COBAN M, Sertoglu E
    Should the neutrophil-lymphocyte ratio be used as a noninvasive marker?
    Eur J Gastroenterol Hepatol. 2015;27:108.
    PubMed     Text format    


  75. MORIHARA D, Watanabe H, Takata K, Iwashita H, et al
    Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.
    Eur J Gastroenterol Hepatol. 2015;27:55-64.
    PubMed     Text format     Abstract available


    October 2014
  76. GRUNWALD D, Kothari D, Malik R
    Noninvasive markers in the assessment and management of autoimmune liver diseases.
    Eur J Gastroenterol Hepatol. 2014;26:1065-72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: